1. At a Glance – India’s Health Insurance King Just Did Something Interesting
Insurance businesses usually hide their truth in ratios.
Banks can hide stress in restructuring.
NBFCs can hide it in growth.
Consumer companies can hide it in branding.
But insurers? They cannot hide forever from the combined ratio.
And this quarter, Star Health did something the market had been waiting years to see.
It dragged the combined ratio below 100.
Not cosmetically.
Not through accounting acrobatics.
Not through one-off reserve releases, if management commentary is to be believed.
FY26 combined ratio improved to 98.8% from 101.1%.
That matters because every percentage point below 100 in insurance is not a statistic. It is underwriting discipline.
Read that again.
For years the criticism around the company was simple:
“Great franchise. Terrible claims inflation.”
Now something seems to be shifting.
Gross Written Premium climbed to ₹20,369 crore, up 16%.
PAT rose to ₹911 crore, up 16%.
Underwriting swung from ₹165 crore loss to ₹206 crore profit.
Retail claims ratio improved.
Renewal ratio touched 99%.
Agency network crossed 8.3 lakh agents.
Those are not random metrics.
That is the skeleton of an insurance compounding machine.
But here comes the detective question.
If this is improving so much… why does the market still value it at a premium multiple but with skepticism?
Because investors are asking:
Is this improvement cyclical?
Or structural?
That is the whole puzzle.
And Star is a fascinating puzzle.
On one hand:
- Dominant retail health franchise.
- 32% retail market share.
- 44% SAHI share.
- Massive proprietary distribution moat.
- Solvency 2.15x.
On the other:
- Medical inflation remains ugly.
- Single-line business concentration risk remains real.
- Investment book volatility under Ind AS/IFRS has become a new headache.
- Expense control still needs watching.
This is not a simple growth story.
It is an underwriting turnaround story disguised as a growth stock.
And those are often where serious money gets interested.
Even stranger—management seems to have actually walked some of what they promised in earlier calls.
Remember Feb 2026 concall?
They pushed three ideas:
- Better combined ratio.
- Better retail mix.
- Better profitability from preferred channels.
FY26 numbers show:
- Combined ratio down.
- Retail dominance stronger.
- Underwriting profitable.
Rare event:
Management may have actually walked the talk.
That alone deserves attention.
But before celebrating, ask yourself:
If a health insurer with 44% SAHI share still earns only ~10% ROE… is the moat bigger than the returns?
That question sits at the heart of this entire story.
And that is where it gets interesting.
2. Introduction – This Is Not Really an Insurance Story. It Is a Pricing Story.
People think health insurance is about claims.
It is not.
It is pricing.
Pricing risk.
Pricing fraud.
Pricing hospitals.
Pricing medical inflation.
Pricing human panic.
That is why this business is hard.
Anyone can sell policies.
Few can price them profitably.
Star has spent years proving it can grow.
FY26 is trying to prove it can grow profitably.
That is a different exam.
Insurance revenue rose to ₹17,999 crore.
Insurance service result rose 46% to ₹1,330 crore.
Claims rose only 10%, slower than premium growth.
That matters.
Because in insurance, slower claims than premiums is poetry.
Management has clearly leaned into three levers:
Pricing discipline
Medical inflation remains brutal.
Management explicitly indicated annual repricing discipline.
This matters because weak insurers underprice growth.
Strong insurers reprice pain.
Better business mix
Retail-to-group mix moved to 95:5 from 91:9 per concall commentary.
That is quietly huge.
Group health often looks large.
Retail often looks profitable.
One impresses headlines.
The other builds value.
Claims control
ANH network, negotiated pricing, fraud controls, digital claims stack.
Boring words.
Beautiful economics.
The market often misses this.
Claims tech can be more valuable than policy growth.
Ask yourself:
Would you rather own an insurer growing 25% with a 103 combined ratio,
or one growing 16% with 98.8?
Exactly.
This is why growth alone is lazy analysis.
Quality of growth matters.
Even channel mix tells a story.
83% agency.
9% digital.
7% banca.
Looks old-school?
Maybe.
But 83 lakh agents are not expense.
Sometimes they are a moat wearing formal shirts.
The bear case says:
“Agency-heavy models are expensive.”
The bull case says:
“Try replicating 8 lakh agents.”
Good luck.
And then there is the subtle thing.
Long-term policy mix in fresh GWP moved from 34% to 51%.
That can improve persistency.
Capital efficiency.
Customer stickiness.
That may be underappreciated.
Insurance rarely rerates because growth accelerates.
It rerates when underwriting quality becomes believable.
That may be where Star is trying to go.
Trying.
Not proven.
Huge difference.
3. Business Model – WTF Do They Even Do?
Imagine a toll booth between Indian households and hospital bills.
That is Star.
People pay premiums.
Hospitals send bills.
Star hopes actuarial science wins.
Sometimes it does.
Sometimes hospitals do.
Business model has five engines:
Retail indemnity health
The crown jewel.
92% revenue mix.
This is the real company.
Everything else is side dishes.
Distribution machine
915 branches.
8 lakh+ agents.
Banca.
Digital.
This is not merely selling insurance.
It is distribution architecture.
Float
